The scientist’s investigation covers issues in PI3K/AKT/mTOR pathway, Protein kinase B, Cancer research, Cell biology and Signal transduction. His studies deal with areas such as Autophagy, Targeted therapy, Leukemia and Cell growth as well as PI3K/AKT/mTOR pathway. The various areas that he examines in his Autophagy study include Computational biology and Physiology.
His work carried out in the field of Protein kinase B brings together such families of science as Jurkat cells, Cellular differentiation, GSK-3, Internal medicine and Pharmacology. His research in Cancer research intersects with topics in Cancer, Kinase, MAPK/ERK pathway, Immunology and PTEN. Within one scientific family, Alberto M. Martelli focuses on topics pertaining to Nuclear protein under Cell biology, and may sometimes address concerns connected to Nuclear matrix.
Alberto M. Martelli mainly investigates Cancer research, Protein kinase B, PI3K/AKT/mTOR pathway, Cell biology and Signal transduction. His Cancer research research is multidisciplinary, relying on both Cancer, Targeted therapy, Leukemia, Immunology and MAPK/ERK pathway. His Protein kinase B research integrates issues from Jurkat cells, Internal medicine and Kinase.
His PI3K/AKT/mTOR pathway research includes elements of Pharmacology and Cell growth. He has researched Cell biology in several fields, including Molecular biology and Biochemistry. His study in Signal transduction is interdisciplinary in nature, drawing from both Cellular differentiation and DNA repair.
Alberto M. Martelli spends much of his time researching Cancer research, Signal transduction, Cancer, PI3K/AKT/mTOR pathway and Protein kinase B. His Cancer research research is multidisciplinary, incorporating perspectives in Pancreatic cancer, Cancer cell, Targeted therapy, Leukemia and MAPK/ERK pathway. His Signal transduction study results in a more complete grasp of Cell biology.
Alberto M. Martelli has included themes like Inducer, Caspase and Protein family in his Cell biology study. Alberto M. Martelli interconnects mTORC1, Radiosensitivity, Disease and Doxorubicin in the investigation of issues within Cancer. The Protein kinase B study combines topics in areas such as Wnt signaling pathway, Cytotoxic T cell, Receptor and PTEN.
Alberto M. Martelli mainly focuses on Cancer research, microRNA, Resveratrol, PI3K/AKT/mTOR pathway and Protein kinase B. His Cancer research research includes themes of Cancer, Gemcitabine, Gene, Hedgehog signaling pathway and Leukemia. His biological study spans a wide range of topics, including Carcinogenesis, Tumor suppressor gene, Cancer stem cell, Internal medicine and Tumor progression.
His Carcinogenesis study integrates concerns from other disciplines, such as Cell cycle, Bcl-2-associated X protein, Mdm2 and Cell biology. His work in Resveratrol addresses issues such as Nutraceutical, which are connected to fields such as Inflammation, Antioxidant, Oxidative stress, Metformin and Cancer cell. His PI3K/AKT/mTOR pathway study focuses mostly on Mechanistic target of rapamycin, mTORC1 and PTEN.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
Linda S. Steelman;William H. Chappell;Stephen L. Abrams;C. Ruth Kempf.
Aging (Albany NY) (2011)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
William H. Chappell;Linda S. Steelman;Jacquelyn M. Long;Ruth C. Kempf.
Oncotarget (2011)
Nuclear localization and signalling activity of phosphoinositidase Cβ in Swiss 3T3 cells
Alberto M. Martelli;R. Stewart Gilmour;Valeria Bertagnolo;Luca M. Neri.
Nature (1992)
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
L. S. Steelman;S. L. Abrams;J. Whelan;F. E. Bertrand.
Leukemia (2008)
GSK-3 as potential target for therapeutic intervention in cancer.
James A. McCubrey;Linda S. Steelman;Fred E. Bertrand;Nicole Marie Davis.
Oncotarget (2014)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
James Andrew McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams.
Oncotarget (2012)
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response
James A McCubrey;Linda S Steelman;William H Chappell;Stephen L Abrams.
Oncotarget (2012)
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.
Alberto M. Martelli;Camilla Evangelisti;Francesca Chiarini;James A. McCubrey.
Oncotarget (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bologna
East Carolina University
University of Ferrara
University of Palermo
University of Bologna
Sapienza University of Rome
University of Ferrara
University of Bologna
East Carolina University
University of Ferrara
TU Dresden
University of Illinois at Chicago
University of Central Florida
University of California, San Diego
London School of Economics and Political Science
Tel Aviv University
SRI International
Chinese Academy of Sciences
University of East Anglia
University of Iceland
University of Waikato
Mayo Clinic
University of Illinois at Chicago
Harvard University
Stanford University
National Institute of Astrophysics, Optics and Electronics